National study of people at risk for rheumatoid arthritis
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study follows people who are at high risk for developing rheumatoid arthritis, as well as first-degree relatives of RA patients and people with very early untreated RA. It aims to learn more about the disease so doctors can better predict and prevent it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You either have certain antibodies (ACPA and rheumatoid factor) that raise your risk for RA, or you are a first-degree relative of someone with RA, or you have very early RA that hasn't been treated yet
- You do not have joint swelling (synovitis) that has been noted by a doctor
- You have never taken background treatments for RA (like methotrexate) or steroids at high doses recently
- You are not pregnant or breastfeeding, and you can follow the study procedures for the duration
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.
This study tests an oral drug called AP1189 for people just diagnosed with active rheumatoid arthritis who haven't yet taken standard arthritis medicines. You may be able to take part if your disease is very active and you're ready to try a new treatment option.
This study looks at a specific antibody in the blood that may help diagnose or monitor rheumatoid arthritis (RA). It aims to see if this marker can distinguish RA from other conditions.
This study is looking at early rheumatoid arthritis (RA) and heart health. It compares people newly diagnosed with RA (within the last 6 months) to healthy people of similar age and sex. The goal is to see if there are early signs of hardening of the arteries in people with RA.
This research study collects samples and information from people with rheumatoid arthritis, lupus, or scleroderma, plus healthy volunteers, to better understand how the immune system works in these conditions. By comparing these groups, researchers hope to find new ways to treat and manage autoimmune diseases.
This study looks at people with early arthritis related to rheumatoid arthritis, psoriatic arthritis, or psoriasis. Researchers want to understand how these early conditions behave and may help guide better treatment decisions.
Hear when a new Rheumatoid Arthritis (RA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.